December 2005

The Medicine Cabinet

January 2, 2008

Compounds have a one in nine chance of making it through development, according to statistics, but even after reaching the market, each compound faces a whole new set of hurdles: physician adoption, reimbursement, and exposure to supply chain vulnerabilities. December 2005 On the Market Advertising/ Consumer Promotion The pros and cons of direct-to-consumer (DTC) advertising […]

Tracking the Trends: The Industry Across Sectors

January 2, 2008

From the clinic to the market to the boardroom, a plethora of factors are expected to change the healthcare landscape in the coming year and beyond. More than 135 distinguished industry executives, representing all of the major sectors of the life-sciences industry, provide their insights on the hot topics and discuss how these market shapers […]

In the Boardroom

January 2, 2008

From defining and redefining organizational business models for big pharma, biotech, and emerging pharma to tactical decisions related to developing generic defense strategies to improving communications and corporate reputation plans to grappling with technology issues, today’s pharmaceutical leaders are relying on business-savvy solutions. Business and Organizational Models According to some industry analysts, the new pharma […]

Year in Preview — Featured Experts

January 2, 2008

Featured Experts Indexed by Section Introduction Introduction Murray Aitken. IMS Health Rudy Bakalov, CISSP. Ernst & Young LLP Daniel B. Carr, M.D. Javelin Pharmaceuticals Inc. Mark A. Goldberg, M.D. Perceptive Informatics, Parexel International Cort Grey. Dendrite Clinical Travis Hollingsworth. Clarkston Consulting Kenneth I. Kaitin. Tufts Center for the Study of Drug Development Mary LaFleur. DVC […]

Year in Preview — Thought Leaders

January 2, 2008

Thought Leaders Listed in Alphabetical Order December 2005 Year in Preview 2006 Meredith Abreu. VP of Research, Manhattan Research LLC, New York; Manhattan Research is a provider of health and pharmaceutical marketing research and strategic analysis. For more information, visit manhattanresearch.com. A.N. Aditya. Research Analyst, Frost & Sullivan, New York; Frost & Sullivan is a […]

Letter from the Editor

January 2, 2008

PharmaVOICE is pleased to present our annual Year in Preview issue. Our thanks to the more than 135 thought leaders who generously took the time to take stock of what they believe are the most-pressing issues the industry will face in the coming year. These hot trends address issues that will impact all areas of […]

In the Clinic: Trials & Tribulations

January 2, 2008

Stakeholders involved with drug development and the clinical-trial process are rising to the challenges to improve efficiencies, reduce costs, and accelerate time lines. Systematic elegant approaches borrowing from areas such as intelligence analysis are at hand. Enhanced product characterization will be achieved with reduced investments. The solution is less about technology and more about a […]

FEEDBACK